Relative frequencies of HPV clades and genotypes in single and multiple infections (n = 647)
| HPV clade/type . | Single infections n (%) . | Multiple Infections n (%) . | Unadjusted OR (95% CI) . | Adjusted OR (95% CI)* . |
|---|---|---|---|---|
| Clade A3 | 24 (39.3) | 37 (60.7) | 0.98 (0.57-1.69) | 0.98 (0.55-1.75) |
| 83 | 14 (35.9) | 25 (64.1) | ||
| 84 | 10 (45.5) | 12 (54.5) | ||
| Clade A5 | 19 (32.8) | 39 (67.2) | 1.35 (0.76-2.39) | 1.34 (0.74-2.42) |
| 26 | 4 (50.0) | 4 (50.0) | ||
| 51 | 14 (34.1) | 27 (65.9) | ||
| 82 | 1 (11.1) | 8 (88.9) | ||
| Clade A6 | 28 (33.0) | 55 (67.0) | 1.30 (0.80-2.11) | 1.15 (0.69-1.92) |
| 53 | 14 (32.6) | 29 (67.4) | ||
| 56 | 4 (30.8) | 9 (69.2) | ||
| 66 | 10 (37.0) | 17 (63.0) | ||
| Clade A7 | 53 (34.9) | 99 (65.1) | 1.26 (0.86-1.85) | 1.36 (0.91-2.02) |
| 18 | 16 (40.0) | 24 (60.0) | ||
| 39 | 8 (47.1) | 9 (52.9) | ||
| 45 | 13 (41.9) | 18 (58.1) | ||
| 59 | 10 (27.8) | 26 (72.2) | ||
| 68 | 6 (21.4) | 22 (78.6) | ||
| Clade A9 | 113 (44.8) | 139 (55.2) | 0.67 (0.48-0.93) | 0.68 (0.48-0.95) |
| 16 | 44 (56.4) | 34 (43.6) | ||
| 31 | 9 (50.0) | 9 (50.0) | ||
| 33 | 2 (14.3) | 12 (85.7) | ||
| 35 | 18 (45.0) | 22 (55.0) | ||
| 52 | 24 (41.4) | 34 (58.6) | ||
| 58 | 16 (36.4) | 28 (63.6) | ||
| Clade A10 | 16 (39.0) | 25 (61.0) | 1.00 (0.52-1.91) | 0.96 (0.48-1.90) |
| 6 | 6 (40.0) | 9 (60.0) | ||
| 11 | 2 (28.6) | 5 (71.4) | ||
| 55 | 8 (42.1) | 11 (57.9) |
| HPV clade/type . | Single infections n (%) . | Multiple Infections n (%) . | Unadjusted OR (95% CI) . | Adjusted OR (95% CI)* . |
|---|---|---|---|---|
| Clade A3 | 24 (39.3) | 37 (60.7) | 0.98 (0.57-1.69) | 0.98 (0.55-1.75) |
| 83 | 14 (35.9) | 25 (64.1) | ||
| 84 | 10 (45.5) | 12 (54.5) | ||
| Clade A5 | 19 (32.8) | 39 (67.2) | 1.35 (0.76-2.39) | 1.34 (0.74-2.42) |
| 26 | 4 (50.0) | 4 (50.0) | ||
| 51 | 14 (34.1) | 27 (65.9) | ||
| 82 | 1 (11.1) | 8 (88.9) | ||
| Clade A6 | 28 (33.0) | 55 (67.0) | 1.30 (0.80-2.11) | 1.15 (0.69-1.92) |
| 53 | 14 (32.6) | 29 (67.4) | ||
| 56 | 4 (30.8) | 9 (69.2) | ||
| 66 | 10 (37.0) | 17 (63.0) | ||
| Clade A7 | 53 (34.9) | 99 (65.1) | 1.26 (0.86-1.85) | 1.36 (0.91-2.02) |
| 18 | 16 (40.0) | 24 (60.0) | ||
| 39 | 8 (47.1) | 9 (52.9) | ||
| 45 | 13 (41.9) | 18 (58.1) | ||
| 59 | 10 (27.8) | 26 (72.2) | ||
| 68 | 6 (21.4) | 22 (78.6) | ||
| Clade A9 | 113 (44.8) | 139 (55.2) | 0.67 (0.48-0.93) | 0.68 (0.48-0.95) |
| 16 | 44 (56.4) | 34 (43.6) | ||
| 31 | 9 (50.0) | 9 (50.0) | ||
| 33 | 2 (14.3) | 12 (85.7) | ||
| 35 | 18 (45.0) | 22 (55.0) | ||
| 52 | 24 (41.4) | 34 (58.6) | ||
| 58 | 16 (36.4) | 28 (63.6) | ||
| Clade A10 | 16 (39.0) | 25 (61.0) | 1.00 (0.52-1.91) | 0.96 (0.48-1.90) |
| 6 | 6 (40.0) | 9 (60.0) | ||
| 11 | 2 (28.6) | 5 (71.4) | ||
| 55 | 8 (42.1) | 11 (57.9) |
NOTE: Values in boldface are statistically significant at P < 0.05.
Calculated from binary logistic regression models simultaneously adjusting for clade, age, HIV status, and Pap smear status.